Medifast Inc. chart

Last update: 2022-12-30
Key statistics and financials
Revenue per share 143.89
Dividend & YieldN/A£ (N/A)
Beta 1.22
Market capitalization 13.51M
Operating cash flow 95.78M
ESG Scores unknown

Company description

Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serves, shakes, smoothies, soft bakes, and soups under the OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home brands. It markets its products through point-of-sale transactions over ecommerce platform. The company was founded in 1980 and is headquartered in Baltimore, Maryland.

Sector: - Industry:

Financial data

Financial Statements

Cashflow Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Change To Liabilities 16.02M 12.11M 28.01M 54.38M
Total Cashflows From Investing Activities -1.2M -6.33M -1.28M -29.06M
Net Borrowings
Total Cash From Financing Activities -53.33M -82.32M -57.14M -125.13M
Change To Operating Activities -217k -4.55M -1.66M -14.43M
Issuance Of Stock 547k 278k 1.6M 811k
Net Income 55.79M 77.92M 102.86M 164.03M
Change In Cash 6.29M -4.39M 86.75M -59.54M
Effect Of Exchange Rate -2k 1k -21k 112k
Total Cash From Operating Activities 60.82M 84.26M 145.2M 94.55M
Depreciation 4.43M 4.62M 4.32M 6.81M
Change To Account Receivables -936k
Other Cashflows From Financing Activities
Change To Netincome 2.11M 9.21M 11.12M 11.35M
Capital Expenditures -4.94M -10.06M -5.89M -34.21M

Income Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Research Development 2.2M 2.7M 2.8M 4.4M
Income Before Tax 70.55M 92.36M 134.26M 216.13M
Net Income 55.79M 77.92M 102.86M 164.03M
Selling General Administrative 308.64M 443.12M 560.86M 906.96M
Gross Profit 379.9M 536.86M 697.82M 1.13B
Ebit 69.06M 91.04M 134.16M 216.24M
Operating Income 69.06M 91.04M 134.16M 216.24M
Interest Expense -231k -231k -231k -231k
Income Tax Expense 14.76M 14.45M 31.41M 52.1M
Total Revenue 501M 713.67M 934.84M 1.53B
Cost Of Revenue 121.1M 176.81M 237.03M 398.49M
Total Other Income ExpenseNet 1.49M 1.32M 106k -112k
Net Income From Continuing Ops 55.79M 77.92M 102.86M 164.03M
Net Income Applicable To Common Shares 55.79M 77.92M 102.86M 164.03M

Balance Sheet Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Total Liabilities 60.32M 89.82M 118.84M 195.85M
Total Stockholder Equity 109.11M 104.83M 157.25M 202.47M
Other Current Liabilities 11.93M 18.05M 21.44M 25.24M
Total Assets 169.43M 194.65M 276.08M 398.33M
Common Stock 12k 12k 12k 12k
Other Current Assets 5.17M 945k
Retained Earnings 131.34M 168.79M 154.35M 190.33M
Treasury Stock -31.05M -63.97M -4.96M 111k
Cash 81.36M 76.97M 163.72M 104.18M
Total Current Liabilities 60.32M 79.39M 111.35M 169.83M
Other Stockholder Equity -173k 25k 41k 111k
Property, Plant, and Equipment 19.75M 38.84M 38.14M 80.59M
Total Current Assets 145.52M 154.15M 234.31M 306.87M
Net Tangible Assets 109.11M 104.83M 157.25M 202.47M
Net Receivables 1.01M 1.44M
Accounts Payable 19.02M 22.61M 36.09M 70.89M


Insider Transactions

Here are the insider transactions of stock shares related to Medifast Inc.:

Filer Name Transaction Text Ownership Date Filer Relation Shares
BROWN JEFFREY JPurchase at price 125.72 - 126.63 per share.I2022-08-09Director3.94k
BROWN JEFFREY JStock Award(Grant) at price 138.78 per share.D2022-08-08Director9
HALLQUIST CONSTANCE JStock Award(Grant) at price 138.78 per share.D2022-08-08Director8
SCHLACKMAN SCOTTStock Award(Grant) at price 138.78 per share.D2022-08-08Director8
HOER MICHAEL A.Stock Award(Grant) at price 138.78 per share.D2022-08-08Director8
THOMAS ANDREA BStock Award(Grant) at price 138.78 per share.D2022-08-08Director8
BROWN JEFFREY JStock Award(Grant) at price 0.00 per share.D2022-06-16Director1.58k
HALLQUIST CONSTANCE JStock Award(Grant) at price 0.00 per share.D2022-06-16Director1.43k
SCHLACKMAN SCOTTStock Award(Grant) at price 0.00 per share.D2022-06-16Director1.45k
HOER MICHAEL A.Stock Award(Grant) at price 0.00 per share.D2022-06-16Director1.35k
THOMAS ANDREA BStock Award(Grant) at price 0.00 per share.D2022-06-16Director1.37k
CHARD DANIEL RPurchase at price 183.25 per share.I2022-05-05Chief Executive Officer431
CHARD DANIEL RStock Gift at price 0.00 per share.D2022-03-21Chief Executive Officer4.33k
CHARD DANIEL RStock Award(Grant) at price 0.00 per share.D2022-03-16Chief Executive Officer8.51k
MALONEY JAMES P.Stock Award(Grant) at price 0.00 per share.D2022-03-16Chief Financial Officer1.28k
MACKENZIE JONATHAN BARRETTStock Award(Grant) at price 0.00 per share.D2022-03-16Officer548
THOMAS ANDREA BSale at price 174.31 per share.D2022-03-10Director1.15k
CHARD DANIEL RPurchase at price 186.40 per share.I2022-02-04Chief Executive Officer690
CHARD DANIEL RStock Gift at price 0.00 per share.D2022-01-03Chief Executive Officer12.54k
CHARD DANIEL RD2021-12-31Chief Executive Officer24.07k
BYRNES KEVIN GConversion of Exercise of derivative security at price 26.52 - 31.55 per share.D2021-11-11Director12.92k
BROWN JEFFREY JPurchase at price 218.49 - 235.28 per share.I2021-11-08Director4.2k
CHARD DANIEL RStock Gift at price 0.00 per share.D2021-11-04Chief Executive Officer90.61k
MACKENZIE JONATHAN BARRETTStock Award(Grant) at price 0.00 per share.D2021-09-13Officer109
BYRNES KEVIN GSale at price 221.99 per share.D2021-08-20Director673
BROWN JEFFREY JPurchase at price 286.16 per share.I2021-08-06Director142
BROWN JEFFREY JStock Gift at price 0.00 per share.D2021-07-07Director1.97k
HALLQUIST CONSTANCE JSale at price 285.09 per share.D2021-07-02Director542
CHARD DANIEL RSale at price 259.32 - 270.10 per share.D2021-06-17Chief Executive Officer6.37k
CHARD DANIEL RSale at price 270.49 - 284.03 per share.D2021-06-16Chief Executive Officer13.52k
CHARD DANIEL RSale at price 278.14 - 293.11 per share.D2021-06-14Chief Executive Officer15.12k
BROWN JEFFREY JStock Award(Grant) at price 0.00 per share.D2021-06-03Director765
BYRNES KEVIN GStock Award(Grant) at price 0.00 per share.D2021-06-03Director650
HALLQUIST CONSTANCE JStock Award(Grant) at price 0.00 per share.D2021-06-03Director679
SCHLACKMAN SCOTTStock Award(Grant) at price 0.00 per share.D2021-06-03Director669
SCHLACKMAN SCOTTStock Award(Grant) at price 0.00 per share.D2021-06-03Director669
HOER MICHAEL A.Stock Award(Grant) at price 0.00 per share.D2021-06-03Director650
THOMAS ANDREA BStock Award(Grant) at price 0.00 per share.D2021-06-03Director659
SCHLACKMAN SCOTTSale at price 310.09 - 311.57 per share.D2021-05-19Director1k
BROWN JEFFREY JPurchase at price 225.04 per share.I2021-05-06Director180
CHARD DANIEL RStock Award(Grant) at price 0.00 per share.D2021-03-17Chief Executive Officer5.5k
MALONEY JAMES P.Stock Award(Grant) at price 0.00 per share.D2021-03-17Chief Financial Officer776
JOHNSON STEPHEN KYLEStock Award(Grant) at price 0.00 per share.D2021-03-17Officer272
HALLQUIST CONSTANCE JSale at price 259.02 per share.D2021-03-03Director4.5k
HALLQUIST CONSTANCE JConversion of Exercise of derivative security at price 27.68 - 28.59 per share.D2021-03-03Director4.5k
BROWN JEFFREY JPurchase at price 240.99 per share.I2021-02-05Director133
BYRNES KEVIN GStock Gift at price 0.00 per share.D2021-01-14Director2k

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to Medifast Inc.. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on Medifast Inc.

Here is the result of two systematic investment strategies applied to Medifast Inc.. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on Medifast Inc.

The following chart shows the equity curve of the two systematic investment strategies applied to Medifast Inc.:

Medifast Inc. automated entries

The systematic investment strategy that buys the first day of the month would give a performance of 0% on the backtest period.

Performance at glance

Performance

0 %

Latent gain

0.0 £

Invested capital

0.0 £

Annualized return

0.0 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on Medifast Inc.

This is the result of two momentum investment strategies applied to Medifast Inc.. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on Medifast Inc.

The following chart shows all the entries opened by the momentum investment system on Medifast Inc.:

Medifast Inc. momentum entries
  • The first momentum investment strategy would give 16.98% of return on Medifast Inc.. That represents 33.31£ of latent gain with 196.15£ of employed capital.
  • The second momentum investment strategy would give 0% of return on Medifast Inc.. That represents 0.0£ of latent gain with 0.0£ of employed capital.
Performance at glance (1Q Momentum)

Performance

16.98 %

Latent gain

33.31 £

Invested capital

196.15 £

Annualized return

-0.0 %
Performance at glance (2Q Momentum)

Performance

0 %

Latent gain

0.0 £

Invested capital

0.0 £

Annualized return

-0.0 %

Momentum equity curve on Medifast Inc.

The following chart shows the equity curve of the two momentum strategies applied to Medifast Inc.:

Medifast Inc. momentum equity

Note: the dividends potentially given by Medifast Inc. are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Medifast Inc.

The following chart shows the employed capital evolution of the two momentum strategies on Medifast Inc. since the beginning:

Medifast Inc.

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250£, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000£.


Buy the dip strategy result on Medifast Inc.

Buy the dip entry openings on Medifast Inc.

Medifast Inc.

The performance achieved by the robo-advisor on Medifast Inc. is 0%. That represents 0.0$ of latent gain with 0.0£ of employed capital. The following chart shows Medifast Inc. stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of Medifast Inc., and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

0 %

Latent gain

0.0 £

Invested capital

0.0 £

Annualized return

-0.0 %

Equity curve of the strategy applied to Medifast Inc.

The following chart shows the result of the investment strategy applied to Medifast Inc.:

Medifast Inc.

Note: the dividends potentially given by Medifast Inc. are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Medifast Inc.

The following chart shows the employed capital evolution since the beginning of the investment strategy on Medifast Inc.:

Medifast Inc.

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on Medifast Inc.

In this section, I will compare the three previous investment strategies applied to Medifast Inc..

Equity curve comparison on Medifast Inc.

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

Medifast Inc. investment strategy comparison

Employed capital comparison on Medifast Inc.

Medifast Inc. investment comparison

Performance comparison on Medifast Inc.

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment 0% 0.0£ 0.0£ 0.0%
Momentum 1 quarter 16.98% 33.31£ 196.15£ 424.5%
Momentum 2 quarters 0% 0.0£ 0.0£ -0.0%
Non-directional 0% 0.0£ 0.0£ -0.0%
Annualized return comparison

Automatic investment

0.0 %

Momentum 1Q

-0.0 %

Momentum 2Q

-0.0 %

Non-directional

-0.0 %

Correlated stocks

Here are the most positively and negatively correlated stocks with Medifast Inc.:

Positive correlations

Most correlated stocks this year


Most correlated stocks last 3 months

Negative correlation

Most negatively correlated stocks this year


Most negatively correlated stocks last 3 months

Note: The algorithm computes the probability of correlation between Medifast Inc. and the other stocks. There may be false positives or some missing correlated stocks. If the price of Medifast Inc. does not vary for 36 weeks, the correlation calculation result will be wrong.


Company information

Company name Medifast Inc.
Country United States
City Baltimore
Address 100 International Drive
Phone 410 581 8042
Website medifastinc.com
FullTime employees 984
Industry
Sector
Exchange XLON
Ticker 0K05.XLON
Market www.londonstockexchange.com

Medifast Inc. ESG Scores

Environment scores

Environment ESG Factors Scores
Environment Score 0
Peer Environment Performance unknown
Environment Percentile unknown
Palm Oil unknown
Nuclear unknown
Fur Leather unknown
GMO unknown
Coal unknown
Pesticides unknown
Animal Testing unknown

Social scores

Social ESG Factors Scores
Social Score 0
Peer Social Performance unknown
Social Percentile unknown
Highest Controversy unknown
Peer Highest Controversy Performance unknown
Adult unknown
Gambling unknown
Alcoholic unknown
Tobacco unknown
Catholic unknown
Controversial Weapons unknown
Small Arms unknown
Military Contract unknown
Peer Count unknown

Related Controversy:


Governance scores

Governance ESG Factors Scores
Governance Score 0
Peer Governance Performance unknown
Governance Percentile unknown

ESG at glance
Total ESG Scores: unknown
Environment Score: 0
Social Score: 0
Governance Score: 0

ESG Performance: unknown

Peer Group: unknown

Peer Esg Score Performance: unknown

Rating Year: unknown

Rating Month: unknown

Max Age: unknown

Percentile: unknown